Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ‐2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001

This publication has 18 references indexed in Scilit:

• Endothelin antagonists for chronic heart failure: do they have a role?
  Published by Oxford University Press (OUP) ,2001
• Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
  New England Journal of Medicine, 2001
• Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS‐II, BEST, AMIOVIRT, V‐MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure
  European Journal of Heart Failure, 2001
• The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)
  European Journal of Heart Failure, 1999
• Update of REACH‐1 and MERIT‐HF clinical trials in heart failure
  European Journal of Heart Failure, 1999
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  The Lancet, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Atrial Fibrillation Follow-Up Investigation of Rhythm Management—The AFFIRM Study Design
  The American Journal of Cardiology, 1997
• Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure
  Journal of Cardiac Failure, 1995